Robeco Institutional Asset Management’s Coupa Software Incorporated COUP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,033
Closed -$120K 1066
2022
Q3
$120K Buy
2,033
+156
+8% +$10.2K ﹤0.01% 872
2022
Q2
$107K Buy
1,877
+30
+2% +$2.31K ﹤0.01% 867
2022
Q1
$188K Buy
1,847
+1,829
+10,161% +$221K ﹤0.01% 850
2021
Q4
$3K Buy
+18
New +$3.71K ﹤0.01% 911
2021
Q3
Sell
-244
Closed -$64K 969
2021
Q2
$64K Sell
244
-1,098
-82% -$272K ﹤0.01% 929
2021
Q1
$341K Buy
1,342
+1,098
+450% +$346K ﹤0.01% 824
2020
Q4
$83K Buy
+244
New +$75.4K ﹤0.01% 903
2020
Q1
Sell
-16,576
Closed -$2.42M 1011
2019
Q4
$2.42M Hold
16,576
0.01% 706
2019
Q3
$2.15M Sell
16,576
-4,700
-22% -$651K 0.01% 703
2019
Q2
$2.69M Hold
21,276
0.01% 663
2019
Q1
$1.94M Buy
21,276
+13,524
+174% +$1.16M 0.01% 712
2018
Q4
$482K Buy
+7,752
New +$490K ﹤0.01% 819

Other funds holding COUP

Robeco Institutional Asset Management's COUP Position: Q4 2022 in Review

Robeco Institutional Asset Management sold out of Coupa Software Incorporated (COUP) in Q4 2022, closing a stake of 2,033 shares — an estimated $120K sold.

Robeco Institutional Asset Management first reported a position in COUP in Q4 2018 and held it in 12 quarters. The position peaked at $2.69M in Q2 2019. 368 funds tracked by Wall St. Rank hold COUP as of Q4 2022.

  • Robeco Institutional Asset Management reported no remaining Coupa Software Incorporated position as of Q4 2022 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 2,033 Coupa Software Incorporated shares in Q4 2022, an estimated $120K.
  • Robeco Institutional Asset Management first reported a position in Coupa Software Incorporated in Q4 2018 and held it in 12 quarters.
  • Robeco Institutional Asset Management's Coupa Software Incorporated position peaked at $2.69M in Q2 2019.
  • 368 funds tracked by Wall St. Rank held Coupa Software Incorporated as of Q4 2022.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.